The clinical treatment effect of androgenetic alopecia with chinese traditional hair growth factor combined with microneedling

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024832

Enrollment

Unknown

Registered

2019-07-29

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic Alopecia

Interventions

experimental side:traditional chinese medicine hair growth fluid combined with micro-needle treatment

control side:traditional chinese medicine hair growth fluid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy males and females aged 18-60 years, all patients meet the clinical diagnostic criteria for androgenetic alopecia, the patient knows and agrees to participate in this experiment, the degree of hair loss meets Norwood male /Hamilton grades III-IV, women meet Ludwig grade I-II.

Exclusion criteria

Exclusion criteria: Physical examination or laboratory examination (routine blood test, Urinary routine, liver and kidney function, autoantibody spectrum, etc.) has obvious abnormalities. It has been corrected for alopecia. The hair loss site has been treated with minoxidil for 1 year, oral antiandrogen drugs, finasteride or other 5a reductase inhibitors, and other causes of alopecia.

Design outcomes

Primary

Measure	Time frame
hair density;hair diameter;	—

Countries

China

Contacts

Public ContactWang Xiaodan

Beijing You'an Hospital, Capital Medical University

bzmcwangxd@163.com+86 18810252752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026